vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Orchid Island Capital, Inc. (ORC). Click either name above to swap in a different company.
Orchid Island Capital, Inc. is the larger business by last-quarter revenue ($38.5M vs $31.1M, roughly 1.2× LIFECORE BIOMEDICAL, INC. \DE\). Orchid Island Capital, Inc. runs the higher net margin — 268.7% vs -32.1%, a 300.8% gap on every dollar of revenue. On growth, Orchid Island Capital, Inc. posted the faster year-over-year revenue change (372.6% vs -4.5%). Over the past eight quarters, Orchid Island Capital, Inc.'s revenue compounded faster (301.6% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Orchid Island Capital, Inc. is a U.S.-based specialty finance company operating as a real estate investment trust. It primarily invests in residential mortgage-backed securities, including agency and non-agency products, targeting consistent risk-adjusted returns for its investors across U.S. fixed income markets.
LFCR vs ORC — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $38.5M |
| Net Profit | $-10.0M | $103.4M |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | — |
| Net Margin | -32.1% | 268.7% |
| Revenue YoY | -4.5% | 372.6% |
| Net Profit YoY | -52.0% | 1764.9% |
| EPS (diluted) | $-0.29 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $38.5M | ||
| Q3 25 | $31.1M | $26.9M | ||
| Q2 25 | — | $23.2M | ||
| Q1 25 | $35.2M | $19.7M | ||
| Q4 24 | $32.6M | — | ||
| Q3 24 | $24.7M | $340.0K | ||
| Q2 24 | — | $-697.0K | ||
| Q1 24 | $35.7M | $-2.5M |
| Q4 25 | — | $103.4M | ||
| Q3 25 | $-10.0M | $72.1M | ||
| Q2 25 | — | $-33.6M | ||
| Q1 25 | $-14.8M | $17.1M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-16.2M | $17.3M | ||
| Q2 24 | — | $-5.0M | ||
| Q1 24 | $15.6M | $19.8M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | — | ||
| Q3 25 | -9.9% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -25.7% | — | ||
| Q4 24 | -6.0% | — | ||
| Q3 24 | -46.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -2.5% | — |
| Q4 25 | — | 268.7% | ||
| Q3 25 | -32.1% | 267.8% | ||
| Q2 25 | — | -145.0% | ||
| Q1 25 | -42.0% | 86.9% | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -65.7% | 5094.1% | ||
| Q2 24 | — | 714.3% | ||
| Q1 24 | 43.8% | -794.2% |
| Q4 25 | — | — | ||
| Q3 25 | $-0.29 | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-0.47 | — | ||
| Q4 24 | $-0.25 | — | ||
| Q3 24 | $-0.53 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.42 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | $665.9M |
| Total DebtLower is stronger | $136.0M | — |
| Stockholders' EquityBook value | $-10.5M | $1.4B |
| Total Assets | $235.2M | $11.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $665.9M | ||
| Q3 25 | $18.9M | $583.9M | ||
| Q2 25 | — | $440.8M | ||
| Q1 25 | $5.4M | $396.4M | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | $322.1M | ||
| Q2 24 | — | $241.0M | ||
| Q1 24 | — | $190.4M |
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | — |
| Q4 25 | — | $1.4B | ||
| Q3 25 | $-10.5M | $1.1B | ||
| Q2 25 | — | $912.0M | ||
| Q1 25 | $2.2M | $855.9M | ||
| Q4 24 | $15.4M | — | ||
| Q3 24 | $-3.9M | $656.0M | ||
| Q2 24 | — | $555.9M | ||
| Q1 24 | $17.7M | $481.6M |
| Q4 25 | — | $11.7B | ||
| Q3 25 | $235.2M | $9.1B | ||
| Q2 25 | — | $7.6B | ||
| Q1 25 | $237.7M | $7.3B | ||
| Q4 24 | $255.4M | — | ||
| Q3 24 | $246.8M | $5.9B | ||
| Q2 24 | — | $4.9B | ||
| Q1 24 | $246.2M | $4.2B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $120.4M |
| Free Cash FlowOCF − Capex | $25.0K | — |
| FCF MarginFCF / Revenue | 0.1% | — |
| Capex IntensityCapex / Revenue | 5.6% | — |
| Cash ConversionOCF / Net Profit | — | 1.16× |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $120.4M | ||
| Q3 25 | $1.8M | $28.0M | ||
| Q2 25 | — | $18.4M | ||
| Q1 25 | $1.2M | $25.8M | ||
| Q4 24 | $-6.1M | — | ||
| Q3 24 | $-613.0K | $-14.8M | ||
| Q2 24 | — | $19.3M | ||
| Q1 24 | $-1.4M | $45.0M |
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
| Q4 25 | — | 1.16× | ||
| Q3 25 | — | 0.39× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.51× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.86× | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.09× | 2.28× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
ORC
Segment breakdown not available.
